AOD9604 Peptide Market Data: 2006 Research, Industry Growth, and Product Comparison Insights
Executive Summary
Abstract: This article examines the AOD9604 peptide market, focusing on its composition as a modified fragment of human growth hormone. Drawing on 2006 research data, it analyzes industry growth trends and provides product comparison insights across purity, dosage forms, and sourcing. Key selection criteria include regulatory compliance, third-party testing, and supplier transparency. The guide offers foundational industry knowledge for researchers and buyers navigating this niche peptide segment.
Target Keyword: aod9604
Core Molecular Specs & Technical Index
AOD9604 peptide is a synthetic modified fragment of the human growth hormone (HGH) C-terminus, specifically comprising amino acids 177-191. This 15-amino-acid peptide is engineered to mimic the lipolytic properties of HGH without affecting growth factors or insulin-like growth factor-1 (IGF-1) levels. For B2B buyers in cosmetic formulation and laboratory research, understanding the precise technical specifications is critical for sourcing and application.
- Molecular Weight: 1813.08 Da, ensuring high solubility in aqueous buffers and compatibility with standard peptide reconstitution protocols.
- Purity Grade: Industry standard is ≥98% by HPLC; premium suppliers offer ≥99% for research-grade applications, minimizing batch-to-batch variability.
- Solubility: Freely soluble in water, PBS, and saline solutions; recommended concentration range is 1-5 mg/mL for optimal stability.
- Storage Requirements: Lyophilized powder stable at -20°C for 24 months; reconstituted solution must be stored at 2-8°C and used within 14 days to prevent degradation.
- Appearance: White to off-white lyophilized powder, free from visible particulates or discoloration, indicating proper manufacturing and handling.
According to a 2006 study published in the Journal of Clinical Endocrinology & Metabolism, AOD9604 peptide demonstrated a 14% reduction in abdominal adipose tissue over 12 weeks in a double-blind, placebo-controlled trial, establishing its foundational efficacy data for metabolic research applications.
Manufacturing & Quality Control
The production of AOD9604 peptide relies on solid-phase peptide synthesis (SPPS) using Fmoc chemistry, followed by cleavage and deprotection. This method ensures high yield and sequence fidelity for the 15-amino-acid chain. Post-synthesis, reversed-phase high-performance liquid chromatography (RP-HPLC) is employed for purification, achieving the required purity thresholds for commercial and research use.
- Production Process: SPPS with automated synthesizers, reducing human error and ensuring consistent chain elongation.
- Purification: RP-HPLC with C18 columns, targeting ≥98% purity; mass spectrometry (MS) confirms molecular weight identity.
- Third-Party Testing: Independent laboratories verify purity, endotoxin levels (<1 EU/mg), and bioactivity via cell-based assays.
- Certifications: ISO 9001:2015 for quality management; GMP compliance for cosmetic-grade peptides; MSDS and COA provided with each batch.
Commercial Application Scenarios
AOD9604 peptide serves multiple B2B sectors, from cosmetic formulation to advanced laboratory research. Its unique mechanism—targeting lipid metabolism without hormonal side effects—makes it a versatile ingredient for product development.
- Cosmetic Formulation: Incorporated into topical creams and serums at 0.1-1% concentration for anti-aging and body contouring products. The peptide enhances lipolysis in subcutaneous fat cells, offering a non-invasive alternative for aesthetic formulations.
- Lab Research: Used in metabolic studies to investigate adipose tissue regulation, mitochondrial function, and energy expenditure. Researchers rely on high-purity AOD9604 peptide for reproducible in vitro and in vivo experiments.
- Bulk Wholesale: Supplied as lyophilized powder in 10 mg, 50 mg, and 100 mg vials for large-scale formulation. Custom packaging and labeling are available for private-label brands seeking market differentiation.
aod9604 peptide VS Ordinary Low-Grade Peptides
| Item | Our Product | Alternatives | Advantages |
|---|---|---|---|
| Purity | ≥99% by HPLC | ≥95% by HPLC | Higher purity reduces impurities and ensures consistent bioactivity in research and formulation. |
| Dosage Forms | Lyophilized powder, sterile vials | Pre-mixed solutions, bulk powder | Lyophilized form offers longer shelf life and flexibility in reconstitution for diverse applications. |
| Sourcing | Direct from GMP-certified manufacturer | Third-party distributors, unverified suppliers | Direct sourcing ensures traceability, lower costs, and full documentation for regulatory compliance. |
| Testing | Third-party HPLC, MS, endotoxin, bioactivity | In-house testing only, limited data | Independent verification guarantees quality and builds trust with end-users and regulatory bodies. |
Bulk Purchase Selection Guide
Navigating the AOD9604 peptide market requires careful evaluation of suppliers and product specifications. Common pitfalls include low-purity batches, inadequate documentation, and misrepresentation of peptide identity. To ensure a successful bulk purchase, follow these selection standards and checklist items.
- Common Pitfalls: Avoid suppliers offering prices significantly below market average, as this often indicates low purity or adulteration. Verify that the peptide sequence matches the AOD9604 standard (amino acids 177-191 of HGH).
- Selection Standards: Require a Certificate of Analysis (COA) with HPLC chromatogram, MS spectrum, and endotoxin results. Prefer suppliers with ISO 9001 or GMP certification and a track record of third-party testing.
- Buyer Checklist: Confirm purity ≥98%, request batch-specific COA, verify storage conditions during shipping, and ask for references from other B2B clients. Ensure the supplier provides technical support for reconstitution and formulation.
Core Product Advantages
Our AOD9604 peptide offers distinct benefits for B2B buyers, focusing on purity, stability, cost performance, and technical support. These advantages streamline procurement and enhance end-product quality.
- Purity: Consistently ≥99% by HPLC, with rigorous third-party testing to eliminate batch variability. This ensures reliable results in research and formulation.
- Stability: Lyophilized powder remains stable for 24 months at -20°C, reducing waste and enabling long-term inventory management. Reconstituted solutions maintain activity for 14 days under refrigeration.
- Cost Performance: Direct manufacturing eliminates intermediary markups, offering competitive pricing for bulk orders (10 mg to 100 g). Volume discounts are available for recurring purchases.
- Technical Support: Our team provides formulation guidance, reconstitution protocols, and regulatory documentation to assist with product development and compliance.
Frequently Asked Questions
Q: What is the recommended storage condition for AOD9604 peptide after reconstitution?
A: After reconstitution in sterile water or PBS, store the solution at 2-8°C and use within 14 days. Avoid freeze-thaw cycles to maintain peptide integrity and bioactivity.
Q: How does AOD9604 peptide differ from full-length human growth hormone in research applications?
A: AOD9604 peptide is a modified fragment (amino acids 177-191) that targets lipolysis without affecting IGF-1 levels or growth promotion. This makes it suitable for metabolic studies where HGH side effects are undesirable.
Q: What documentation should I request from a supplier to ensure quality compliance?
A: Request a Certificate of Analysis (COA) with HPLC purity data, mass spectrometry confirmation, endotoxin levels, and bioactivity assay results. Also ask for ISO or GMP certification and batch-specific documentation for traceability.